Jenburkt Pharma

{
  "main_header": {
    "sid": 134395,
    "name": "Jenburkt Pharma",
    "stock_name": "Jenburkt Pharma",
    "full_name": "Jenburkt Pharmaceuticals Ltd.",
    "name_url": "stocks-analysis/jenburkt-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,141.00",
    "chg": 13.85,
    "chgp": "1.23%",
    "dir": 1,
    "prev_price": "1,127.15",
    "mcapval": "504.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524731,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE354A01013",
    "curr_date": "Jun 04, 10:02 AM",
    "curr_time": "10:12 AM",
    "last_traded_at": "Jun 04, 10:02 AM IST",
    "bse_nse_vol": "143 ",
    "exc_status": "Active",
    "traded_date": "Jun 04, 2026",
    "traded_date_str": "2026 06 04",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/jenburkt-pharma-134395-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Jenburkt Pharmaceuticals Ltd. Technical Momentum Shifts Amid Mixed Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jenburkt-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-indicators-4029023",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/JenburktPharmac_technicaldot_4029023.png",
        "date": "2026-06-02 08:00:30",
        "description": "Jenburkt Pharmaceuticals Ltd., a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. This transition is underscored by a complex interplay of technical indicators, including MACD, RSI, Bollinger Bands, and moving averages, which collectively paint a nuanced picture of the stock’s near-term prospects."
      },
      {
        "title": "Jenburkt Pharmaceuticals Ltd. is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jenburkt-pharmaceuticals-ltd-is-rated-hold-4013572",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/JenburktPharmac_mojoScore_4013572.png",
        "date": "2026-05-26 10:10:03",
        "description": "Jenburkt Pharmaceuticals Ltd. is rated 'Hold' by MarketsMOJO, with this rating last updated on 05 May 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 26 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Jenburkt Pharmaceuticals Ltd. Shows Technical Momentum Shift Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jenburkt-pharmaceuticals-ltd-shows-technical-momentum-shift-amid-mixed-indicator-signals-4012375",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/JenburktPharmac_technicaldot_4012375.png",
        "date": "2026-05-26 08:00:33",
        "description": "Jenburkt Pharmaceuticals Ltd., a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently exhibited a shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, reflecting a nuanced market sentiment as the stock trades near ₹1,171.40."
      },
      {
        "title": "Jenburkt Pharmaceuticals Ltd. Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jenburkt-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-market-signals-4000004",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/JenburktPharmac_technicaldot_4000004.png",
        "date": "2026-05-20 08:00:21",
        "description": "Jenburkt Pharmaceuticals Ltd., a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently experienced a notable shift in its technical momentum. After a period of mild bearishness, the stock’s technical indicators now suggest a sideways trend, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. This article analyses the latest technical parameters, price momentum, and relative performance against the broader market to provide a comprehensive view for investors."
      },
      {
        "title": "Jenburkt Pharmaceuticals Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jenburkt-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3997682",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/JenburktPharmac_technicaldot_3997682.png",
        "date": "2026-05-19 08:00:26",
        "description": "Jenburkt Pharmaceuticals Ltd., a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently experienced a notable shift in its technical momentum. After a period of sideways movement, the stock’s technical parameters now indicate a mildly bearish trend, reflecting a complex interplay of bullish and bearish signals across key indicators such as MACD, RSI, Bollinger Bands, and moving averages. This article analyses these technical developments in detail, contextualising them within the stock’s recent price action and broader market performance."
      },
      {
        "title": "Jenburkt Pharmaceuticals Ltd. is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jenburkt-pharmaceuticals-ltd-is-rated-hold-3992638",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/JenburktPharmac_mojoScore_3992638.png",
        "date": "2026-05-15 10:10:02",
        "description": "Jenburkt Pharmaceuticals Ltd. is rated 'Hold' by MarketsMOJO, with this rating last updated on 05 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 May 2026, providing investors with the most up-to-date view of the company’s performance and prospects."
      },
      {
        "title": "Jenburkt Pharmaceuticals Ltd. Exhibits Technical Momentum Shift Amid Market Recovery",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jenburkt-pharmaceuticals-ltd-exhibits-technical-momentum-shift-amid-market-recovery-3990286",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/JenburktPharmac_technicaldot_3990286.png",
        "date": "2026-05-14 08:00:14",
        "description": "Jenburkt Pharmaceuticals Ltd., a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently exhibited a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend. This change is underscored by a blend of bullish and bearish signals across key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, reflecting a complex market sentiment as the stock trades near ₹1,176.75."
      },
      {
        "title": "Jenburkt Pharmaceuticals Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jenburkt-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3986243",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/JenburktPharmac_technicaldot_3986243.png",
        "date": "2026-05-12 08:00:29",
        "description": "Jenburkt Pharmaceuticals Ltd., a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. This transition is underscored by a complex interplay of technical indicators, including MACD, RSI, Bollinger Bands, and moving averages, which collectively paint a nuanced picture of the stock’s near-term prospects."
      },
      {
        "title": "Jenburkt Pharmaceuticals Gains 11.59%: 3 Key Factors Driving the Surge",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jenburkt-pharmaceuticals-gains-1159-3-key-factors-driving-the-surge-3984316",
        "imagepath": "",
        "date": "2026-05-10 16:01:01",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>4 May:</strong> Week opens at Rs.1,042.20</p>\n                    <p><strong>6 May:</strong> Q4 FY26 results reveal margin expansion</p>\n                    <p><strong>7 May:</strong> Technical momentum shift and valuation upgrade</p>\n                    <p><strong>8 May:</strong> Week closes at Rs.1,162.95 (-0.58% on day)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,042.20</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.1,162.95</div><div class=\"stat-change positive\">+11.59%<..."
      }
    ],
    "total": 513,
    "sid": "134395",
    "stock_news_url": "https://www.marketsmojo.com/news/jenburkt-pharmaceuticals-134395"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "27-May-2026",
      "details": "Newspaper Advertisement for giving notice for the purpose of transfer of unclaimed dividend and corresponding equity shares of the Company to IEPFA.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
      "datetime": "07-May-2026",
      "details": "Annual Secretraial Compliance Report for the financial year ended 31st March 2026.",
      "source": "BSE"
    },
    {
      "caption": "Intimation Of Record Date And Cut-Off Date",
      "datetime": "06-May-2026",
      "details": "The Company has fixed Friday 28th August 2026 as the Record date for the Payment of Dividend for the Financial Year 2025-26 as well as cut-off date for Remote e-voting and e-voting during the 41st AGM.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Jenburkt Pharmaceuticals Ltd. has declared <strong>180%</strong> dividend, ex-date: 11 Jul 25",
          "dt": "2025-07-11",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Jenburkt Pharmaceuticals Ltd. Technical Momentum Shifts Amid Mixed Indicators

2026-06-02 08:00:30

Jenburkt Pharmaceuticals Ltd., a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. This transition is underscored by a complex interplay of technical indicators, including MACD, RSI, Bollinger Bands, and moving averages, which collectively paint a nuanced picture of the stock’s near-term prospects.

Read full news article

Jenburkt Pharmaceuticals Ltd. is Rated Hold

2026-05-26 10:10:03

Jenburkt Pharmaceuticals Ltd. is rated 'Hold' by MarketsMOJO, with this rating last updated on 05 May 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 26 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Jenburkt Pharmaceuticals Ltd. Shows Technical Momentum Shift Amid Mixed Indicator Signals

2026-05-26 08:00:33

Jenburkt Pharmaceuticals Ltd., a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently exhibited a shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, reflecting a nuanced market sentiment as the stock trades near ₹1,171.40.

Read full news article

Jenburkt Pharmaceuticals Ltd. Technical Momentum Shifts Amid Mixed Market Signals

2026-05-20 08:00:21

Jenburkt Pharmaceuticals Ltd., a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently experienced a notable shift in its technical momentum. After a period of mild bearishness, the stock’s technical indicators now suggest a sideways trend, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. This article analyses the latest technical parameters, price momentum, and relative performance against the broader market to provide a comprehensive view for investors.

Read full news article

Jenburkt Pharmaceuticals Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals

2026-05-19 08:00:26

Jenburkt Pharmaceuticals Ltd., a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently experienced a notable shift in its technical momentum. After a period of sideways movement, the stock’s technical parameters now indicate a mildly bearish trend, reflecting a complex interplay of bullish and bearish signals across key indicators such as MACD, RSI, Bollinger Bands, and moving averages. This article analyses these technical developments in detail, contextualising them within the stock’s recent price action and broader market performance.

Read full news article

Jenburkt Pharmaceuticals Ltd. is Rated Hold

2026-05-15 10:10:02

Jenburkt Pharmaceuticals Ltd. is rated 'Hold' by MarketsMOJO, with this rating last updated on 05 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 May 2026, providing investors with the most up-to-date view of the company’s performance and prospects.

Read full news article

Jenburkt Pharmaceuticals Ltd. Exhibits Technical Momentum Shift Amid Market Recovery

2026-05-14 08:00:14

Jenburkt Pharmaceuticals Ltd., a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently exhibited a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend. This change is underscored by a blend of bullish and bearish signals across key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, reflecting a complex market sentiment as the stock trades near ₹1,176.75.

Read full news article

Jenburkt Pharmaceuticals Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals

2026-05-12 08:00:29

Jenburkt Pharmaceuticals Ltd., a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. This transition is underscored by a complex interplay of technical indicators, including MACD, RSI, Bollinger Bands, and moving averages, which collectively paint a nuanced picture of the stock’s near-term prospects.

Read full news article

Jenburkt Pharmaceuticals Gains 11.59%: 3 Key Factors Driving the Surge

2026-05-10 16:01:01

Key Events This Week

4 May: Week opens at Rs.1,042.20

6 May: Q4 FY26 results reveal margin expansion

7 May: Technical momentum shift and valuation upgrade

8 May: Week closes at Rs.1,162.95 (-0.58% on day)

Week Open

Rs.1,042.20

Week Close

Rs.1,162.95

+11.59%<...

Read full news article

View All News